Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Activity and safety of fenspiride in bronchial hyperexudation (author's transl)
Ist Teil von
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1979-10, Vol.55 (33-34), p.1549
Ort / Verlag
France
Erscheinungsjahr
1979
Quelle
MEDLINE
Beschreibungen/Notizen
This clinical trial of fenspiride (injectable and sustained-release 80 mg tablet) was carried out on patients selected because their bronchopathy was of a hypersecretory type. Interesting results were observed in 20 out of 37 cases, but they were often delayed. This group of patients included a high proportion of patients with major hypersecretion; the efficacy of fenspiride is often evident, (in 8 out of 11 cases) but it is unpredictable individually. It can be concluded from this trial that a long term treatment with fenspiride, well tolerated, can usefully be tried in patients with predominant signs of bronchial hyperexudation.